Narrative review / 2011
Preclinical and clinical trials support green tea's chemopreventive effects in prostate cancer, while epidemiological findings remain mixed.
This review summarizes epidemiological, human clinical, animal, and in vitro mechanistic studies assessing green tea (GT) and black tea (BT) in prostate cancer (CaP). GT contains higher concentrations of monomeric polyphenols leading to higher circulating polyphenol levels, whereas BT polymers are converted by gut microflora into phenolic acids. In vitro, animal, and clinical intervention studies provide strong evidence supporting GT extracts or EGCG in CaP chemoprevention, though epidemiological results are mixed. Chemopreventive evidence for BT is weaker, although several animal studies show inhibition of CaP growth.
- Study type
- Review
- Who was studied
- Human clinical, epidemiological, animal, and in vitro models
- What was measured
- Prostate cancer chemoprevention and tumor growth
THE PAPER
Chemopreventive effects of tea in prostate cancer: green tea versus black tea.
Henning SM, Wang P, Heber D. Mol Nutr Food Res, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.